Table of Content

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Tardive Dyskinesia Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Tardive Dyskinesia Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Tardive Dyskinesia Market by Type
5.1. Introduction
5.2. General tardive dyskinesia
5.3. Hyperlipidemia
5.4. Combined Hyperlipidemia
5.5. Hypoalphalipoproteinemia
6. Global Tardive Dyskinesia Market by Drug Class
6.1. Introduction
6.2. Statin Drugs
6.3. Non-Statin Lipid–Lowering Drugs
7. Global Tardive Dyskinesia Market by End User
7.1. Introduction
7.2. Hospitals
7.3. Homecare
7.4. Specialty Clinics
7.5. Other End Users
8. Global Tardive Dyskinesia Market by Region
8.1. Introduction
8.2. United States
8.3. Germany
8.4. France
8.5. United Kingdom
8.6. Italy
8.7. Spain
8.8. Japan
8.9. Rest of the World
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Abbott Laboratories.
12.2.2. Amgen Inc
12.2.3. Bausch Health
12.2.4. Bionpharma
12.2.5. GlaxoSmithKline Plc.
12.2.6. Johnson & Johnson Services, Inc.
12.2.7. Lannett Co Inc
12.2.8. Lilly
12.2.9. Lupin Pharmaceuticals Inc
12.2.10. Medicure Inc
12.2.11. Mylan N.V
12.2.12. Neurocrine Biosciences, Inc
12.2.13. Novartis AG
12.2.14. Sanofi
12.2.15. Teva Pharmaceutical Industries
?

List of Figures

Figure 1: Global Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 2: Global Tardive Dyskinesia Market by Type, 2023
Figure 3: Global Tardive Dyskinesia Market by Drug Class, 2023
Figure 4: Global Tardive Dyskinesia Market by End User, 2023
Figure 5: Global Tardive Dyskinesia Market by Region, 2023
Figure 6: Global Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 7: Global Tardive Dyskinesia Market by Type (in %), 2023 & 2033
Figure 8: Global General Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 9: Global General Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 10: Global Bradykinesias Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 11: Global Bradykinesias Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 12: Global Hyperkinesias Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 13: Global Hyperkinesias Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 14: Global Tardive Dyskinesia Market by Drug Class (in %), 2023 & 2033
Figure 15: Global Dopamine-Depleting Medications Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 16: Global Dopamine-Depleting Medications Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 17: Global VMAT2 Inhibitors Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 18: Global VMAT2 Inhibitors Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 19: Global GABA Receptor Agonist Medications Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 20: Global GABA Receptor Agonist Medications Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 21: Global Anticholinergic Medications Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 22: Global Anticholinergic Medications Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 23: Global Tardive Dyskinesia Market by End User (in %), 2023 & 2033
Figure 24: Global Hospitals Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 25: Global Hospitals Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 26: Global Clinics Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 27: Global Clinics Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 28: Global Other End Users Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 29: Global Other End Users Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 30: Global Tardive Dyskinesia Market by Region (in %), 2023 & 2033
Figure 31: United States Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 32: United States Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 33: Germany Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 34: Germany Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 35: France Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 36: France Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 37: United Kingdom Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 38: United Kingdom Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 39: Italy Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 40: Italy Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 41: Spain Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 42: Spain Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 43: Japan Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 44: Japan Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 45: Rest of the World Tardive Dyskinesia Market (in US$ Million), 2019-2023
Figure 46: Rest of the World Tardive Dyskinesia Market (in US$ Million), 2024-2033
Figure 47: Market Value Chain


List of Tables

Table 1: Global Tardive Dyskinesia Market Portraiture
Table 2: Global Tardive Dyskinesia Market by Type (in US$ Million), 2023 & 2033
Table 3: Global Tardive Dyskinesia Market by Drug Class (in US$ Million), 2023 & 2033
Table 4: Global Tardive Dyskinesia Market by Channel (in US$ Million), 2023 & 2033
Table 5: Global Tardive Dyskinesia Market by End User (in US$ Million), 2023 & 2033
Table 6: Global Tardive Dyskinesia Market by Region (in US$ Million), 2023 & 2033
Table 7: List of Key Players